A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival
Abstract Purpose To develop a prognostic test based on a single blood sample obtained at the time of uveal melanoma diagnosis. Methods 83 patients diagnosed with posterior uveal melanoma between 1996 and 2000 were included. Peripheral serum samples were obtained at diagnosis and kept at -80 °C until...
Main Authors: | Christina Herrspiegel, Flavia Plastino, Emma Lardner, Stefan Seregard, Pete A. Williams, Helder André, Gustav Stålhammar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10757-x |
Similar Items
-
Editorial: Uveal melanoma: from lab bench to clinic – new therapeutic advances
by: Agata Grazia D'Amico, et al.
Published: (2023-06-01) -
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
by: Anna Hagström, et al.
Published: (2022-04-01) -
Natural antitumor resistance of the organism condition of patients with uveal melanoma of small sizes
by: S.I. Polyakova, et al.
Published: (2016-02-01) -
VITREORETINAL SURGERY IN THE COMBINED TREATMENT OF UVEAL MELANOMA
by: Navumenka L. V., et al.
Published: (2020-06-01) -
Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients
by: Viktor Gill, et al.
Published: (2022-06-01)